An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma

Ooi, Aikseng, Wong, Jing-Chii, Petillo, David, Roossien, Douglas, Perrier-Trudova, Victoria, Whitten, Douglas, Min, Bernice Wong Hui, Tan, Min-Han +9 more·2011·Cancer Cell
DOI 10.1016/j.ccr.2011.08.024

Cited by (405)

Items 301–400 of 405

  1. Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
    Pamela Sarkar, Juliana Redondo, Kelly M Hares, Stephen H. Bailey, Anastasia Georgievskaya, Kate J. Heesom, Kevin C. Kemp, Neil J. Scolding, Claire M Rice · 2021 · Multiple Sclerosis Journal
  2. FOXA2 controls the anti-oxidant response in FH-deficient cells
    Connor Rogerson, Marco Sciacovelli, Lucas A. Maddalena, Andromachi Pouikli, Marc Segarra‐Mondejar, Lorea Valcárcel-Jiménez, Christina Schmidt, Ming Hui Yang, Elena Ivanova, Joshua Kent et al. · 2023 · Cell Reports
  3. Renal Cell Carcinoma Deep Sequencing: Recent Developments
    Leslie J. Farber, Kyle Furge, Bin Tean Teh · 2012 · Current Oncology Reports
  4. Therapeutic Strategies for Hereditary Kidney Cancer
    Abhinav Sidana, Ramaprasad Srinivasan · 2016 · Current Oncology Reports
  5. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma
    Yi Duan, Dong Zhang · 2019 · Journal of Cellular Biochemistry
  6. Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc
    Carole Sourbier, Christopher J. Ricketts, Pei‐Jyun Liao, Shingo Matsumoto, Darmood Wei, Martin Lang, Reema S. Railkar, Youfeng Yang, Ming-Hui Wei, Piyush Kumar Agarwal et al. · 2019 · Scientific Reports
  7. Nrf2 protein in melanoma progression, as a new means of treatment
    Qun Feng, Xiaolin Xu, Shoulin Zhang · 2023 · Pigment Cell & Melanoma Research
  8. The Metabolic Basis of Kidney Cancer
    Ramaprasad Srinivasan, Arvin Koruthu George, William Marston Linehan · 2015 · Springer eBooks
  9. Excess cysteine drives conjugate formation and impairs proliferation of NRF2-activated cancer cells
    Jennifer A. Brain, Anna-Lena B.G. Vigil, Kristian Davidsen, Ayaha Itokawa, Abby C Jurasin, Hannah J. Kerbyson, Maximilian Kobiesa, Madeleine L. Hart, Sang Jun Yoon, Peter Bellotti et al. · 2026 · Nature Metabolism
  10. Iron chelators as mitophagy agents: Potential and limitations
    Tereza Brogyányi, Zdeněk Kejík, Kamila Veselá, Petr Dytrych, David Hoskovec, Michal Masařík, Petr Babula, Robert Kaplánek, Tomáš Přibyl, Jaroslav Zelenka et al. · 2024 · Biomedicine & Pharmacotherapy
  11. Oxygen needs sulfur, sulfur needs oxygen: a relationship of interdependence
    Hiroki Sekine, Takaaki Akaike, Hozumi Motohashi · 2025 · The EMBO Journal
  12. Chromatin Helicase CHD6 Establishes Proinflammatory Enhancers and Is a Synthetic Lethal Target in FH-Deficient Renal Cell Carcinoma
    Juan Jin, Jun Luo, Xiaodong Jin, Kiat Shenq Lim, Yang He, Jiawei Ding, Yan Shen, Yuchen Hou, Hanqing Liu, Xiaoyu Zhu et al. · 2024 · Cancer Research
  13. Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators
    Jeyun Jo, Lara H. Ibrahim, Jonathan Iaconelli, Jinsook Kwak, Manoj Kumar, Yunjin Jung, Luke L. Lairson, Arnab K. Chatterjee, Peter G. Schultz, Michael J. Bollong et al. · 2021 · Bioorganic Chemistry
  14. NRF2 activation in cancer and overview of NRF2 small molecule inhibitors
    Hoang Hai Ngo, Bo-Yeong Yu, Jeong‐Eun Lee, Hyun Woo Kim, Young‐Sam Keum · 2025 · Archives of Pharmacal Research
  15. Immunometabolites and cancer: the role of 2-hydroxyglutarate, succinate, fumarate and itaconate in tumour development and anti-tumour immunity
    Thomas Pfefer, Anna Hanga Bessenyei, Luke A.J. O'Neill · 2026 · Immunology Letters
  16. The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral center.
    Thomas Scharnitz, Mio Nakamura, Erika S. Koeppe, Marie-Louise Henry, Lori Lowe, Tobias Else, Kelly B Cha · 2023 · PubMed Central
  17. The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023
    Toni K. Choueiri, Sumanta Kumar Pal, Bryan Lewis, Susan Poteat, Kevin Pels, Hans J. Hammers · 2023 · The Oncologist
  18. Consensus on clinical diagnosis and treatment of fumarate hydratase-deficient renal cell carcinoma
    Yu Shen, Zhenhua Liu, Qiang Wei, Wei Xue · 2024 · Holistic Integrative Oncology
  19. Insights into the role of NRF2 in cancer provided by cancer genomics
    Petri Pölönen, Anna–Liisa Levonen · 2016 · Current Opinion in Toxicology
  20. Selective inhibition of TGF-β-induced epithelial-mesenchymal transition overcomes chemotherapy resistance in high-risk lung squamous cell carcinoma
    Liangdong Sun, Jue Wang, Huansha Yu, Xinsheng Zhu, Jing Zhang, Junjie Hu, Yilv Yan, Xun Zhang, Yuming Zhu, Gening Jiang et al. · 2025 · Communications Biology
  21. Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes
    Kai Zhang, Hang‐Mao Lee, Gong‐Hong Wei, Aki Manninen · 2016 · Oncotarget
  22. NRF2 activation in cancer cells suppresses immune infiltration into the tumor microenvironment
    Huaichun Wen, Takafumi Suzuki, Anqi Zhang, Miu Sato, Mahiro Matsumoto, Yuka Takahashi, Yushi Takahashi, Masayuki P. Yamamoto · 2025 · iScience
  23. CDC5L drives FAH expression to promote metabolic reprogramming in melanoma
    Zhichao Gu, Huafeng Zhang, Yong Li, Susu Shen, Xiaonan Yin, Wei Zhang, Ruimin Cheng, Yong Zhang, Xiaoyan Zhang, Hui Chen et al. · 2017 · Oncotarget
  24. Cancer of the Kidney
    Megan Ann McNamara, Tian Zhang, Michael Roger Harrison, Daniel J. George · 2020 · Elsevier eBooks
  25. Metabolism and Oxidative Stress Response Pathways in Kidney Cancer: A Tale of Chance and Necessity
    Carole Sourbier, Ramaprasad Srinivasan, William Marston Linehan · 2015 · American Society of Clinical Oncology Educational Book
  26. Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
    Yue Wang, Xi Tian, Shuxuan Zhu, Wenhao Xu, Aihetaimujiang Anwaier, Jiaqi Su, Hualei Gan, Yuanyuan Qu, Jian‐Yuan Zhao, Hai‐Liang Zhang et al. · 2023 · World Journal of Surgical Oncology
  27. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses
    Mukul K. Divatia, Ziad M. El‐Zaatari · 2020 · Indian Journal of Pathology and Microbiology
  28. The KEAP1-NRF2 system and neurodegenerative diseases
    Akira Uruno, Masayuki P. Yamamoto · 2023 · Antioxidants and Redox Signaling
  29. Genetics of Renal Cell Carcinoma
    Mark Wayne Ball, William Marston Linehan · 2018 · Springer eBooks
  30. Novel Insights into FH-associated Disease are KEAPing the Lid on Oncogenic HIF Signalling
    Julie Adam, Peter John Ratcliffe, Patrick J. Pollard · 2011 · Oncotarget
  31. Global chemical modifications comparison of human plasma proteome from two different age groups
    Yongtao Liu, Xuanzhen Pan, Mindi Zhao, Youhe Gao · 2020 · Scientific Reports
  32. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation
    Takao Kamai, Satoshi Murakami, Kyoko Arai, Daisaku Nishihara, Toshitaka Uematsu, Kazuyuki Ishida, Toshiki Kijima · 2022 · BMC Cancer
  33. Heat Shock Protein 70 (HSP70) Family in Dengue Virus Infection
    Rattiyaporn Kanlaya, Visith Thongboonkerd · 2018 · Heat shock proteins
  34. A novel method to identify pathways associated with renal cell carcinoma based on a gene co-expression network
    Xiyun Ruan, Hongyun Li, BO LIU, Jie Chen, SHIBAO ZHANG, Zeqiang Sun, Shuangqing Liu, Fahai Sun, Qingyong Liu · 2015 · Oncology Reports
  35. The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer
    Anqi Wu, Hao Li, Meng Qiu Gao, Juan Boo Liang, Jiaqi Huang, Jaume Farrés, Deliang Cao, Guoqing Li · 2024 · Frontiers in Immunology
  36. Histopathologie und Molekularpathologie des Nierenzellkarzinoms
    Christine Stöhr, Kerstin Amann, Arndt Hartmann · 2014 · Der Onkologe
  37. Nrf2 – Two Faces of Antioxidant System Regulation
    Michal Pastorek, Petr Müller, Bořivoj Vojtěšek · 2015 · Klinicka onkologie
  38. Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators
    Jeyun Jo, Jisu Kim, Lara H. Ibrahim, Manoj Kumar, Jonathan Iaconelli, Cong So Tran, Hyung Ryong Moon, Yunjin Jung, R. Luke Wiseman, Luke L. Lairson et al. · 2023 · Bioorganic & Medicinal Chemistry Letters
  39. Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
    Claudia Tanja Mierke · 2020 · Biological and medical physics, biomedical engineering
  40. Histopathologie des Nierenzellkarzinoms
    Christine Stöhr, Kerstin Amann, Arndt Hartmann · 2013 · Der Urologe
  41. Molecular Genetics of Renal Cell Carcinoma
    Tomoya Fukawa, Nicholas Brian Shannon, Dachuan Huang, Jing Ying Tan, Xiaosai Yao, Steve Rozen, Patrick Tan, Bin Tean Teh · 2017 · Springer eBooks
  42. Hereditary Renal Cell Carcinoma
    Masaya Baba, Laura S. Schmidt, William Marston Linehan · 2017 · Springer eBooks
  43. Cancer of the Kidney
    Роберто Пили, ERIC C. KAUFFMAN, Ronald Rodríguez · 2014 · Elsevier eBooks
  44. Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists’ ever-expanding differential diagnosis for a heterogeneous group of entities
    Alexander S. Taylor, Stephanie L. Skala · 2021 · Urologic Oncology Seminars and Original Investigations
  45. Correction: Corrigendum: How cancer metabolism is tuned for proliferation and vulnerable to disruption
    Almut Schulze, Adrian Llewellyn Harris · 2013 · Nature
  46. Papillary Renal-Cell Carcinoma
    William Marston Linehan, Maria J Merino, Christopher J. Ricketts · 2016 · New England Journal of Medicine
  47. KEAP1 mutations activate the NRF2 pathway to drive cell growth and migration, and attenuate drug response in thyroid cancer
    Nicholas E. Bambach, Julio C. Ricarte‐Filho, Erin Renée Reichenberger, Christian Hernandez-Padilla, Kyle Hinkle, Amber R. Isaza, Andrew J. Bauer, Aime T. Franco · 2026 · Frontiers in Oncology
  48. Multiple Cutaneous and Uterine Leiomyomatosis
    Teruhiko Makino · 2013 · InTech eBooks
  49. Metabolic Reprogramming of Cancer Stem Cells and a Novel Eight-Gene Metabolism-Related Risk Signature in Clear Cell Renal Carcinoma
    Lu Feng Pang, Yanfeng Hou, Xin Wang, Jialin Du, Haiming Huang, Ming‐Yu Yang, Sisi Wang, Chongwen An, Tao Meng, Haixia Li · 2023 · Current Chinese Science
  50. HPPE Activates NRF2 Signaling by Liberating Heavy Metal Stores
    Rebecca Freeman, Michael J. Bollong · 2024 · ChemBioChem
  51. Exploiting NRF2 ‐ ARE pathway activation in papillary renal cell carcinoma
    Silvia Angori, Harini Lakshminarayanan, Amir Banaei‐Esfahani, Katharina Mühlbauer, Hella Anna Bolck, Olli Kallioniemi, Vilja Pietiäinen, Peter Schraml, Holger Moch · 2024 · International Journal of Cancer
  52. Damage-associated molecular patterns as metabolic regulators of innate immunity
    Tristram A.J. Ryan, Ivan Zanoni, Marco Di Gioia · 2025 · Elsevier eBooks
  53. P4HB, a novel succinated protein, is essential for fumarate-induced cancer metastasis
    Xinyi Song, Haipeng Rao, Chunchun Huang, Miaoling Huang, Ying Ma, Jingyu Xin, Jiajia Hou, Zhigang Hu, Lingfeng He, Feiyan Pan et al. · 2025 · International Journal of Biological Macromolecules
  54. DisABLing Kidney Cancers Caused by Fumarate Hydratase Mutations
    William G. Kaelin · 2014 · Cancer Cell
  55. Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation
    Carolina Arenas Valencia, Liliana López Kleine, Andrés Mauricio Pinzón Velasco, Andrea Yimena Cardona Barreto, Clara Eugenia Arteaga Díaz · 2018 · Familial Cancer
  56. Cancer Cell Metabolism Featuring Nrf2
    Payal Chatterjee, Mukesh Yadav, Namrata Chauhan, Ying Sheng Huang, Yun Luo · 2018 · Current Drug Discovery Technologies
  57. Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine.
    Roy M. Elias, Akanksha Sharma, Nirmish Singla, James Brugarolas · 2019 · PubMed
  58. Oxidative Stress and Cancer: Role of the Nrf2-Antioxidant Response Element Signaling Pathway
    Munindra Ruwali, Rahul Shukla · 2021 · Springer eBooks
  59. Metabolic Imbalance Associated Mitophagy in Tumor Cells: Genesis and Implications
    Madhuri Chaurasia, Shashank Misra, Anant Narayan Bhatt, Asmita Das, Bilikere Srinivasa Rao Dwarakanath, Kulbhushan Sharma · 2015 · Journal of cancer research updates
  60. Sensing Oxidative Stress: The NRF2 Signaling Pathway
    Montserrat Rojo de la Vega, Matthew B. Dodson, D.D. Zhang · 2017 · Elsevier eBooks
  61. Molecular Biology and Genetics of Renal Cell Carcinoma
    Sanaz Noelle Ghafouri, David C. Johnson, Kristen Kelly, Allan J. Pantuck, Alexandra Drakaki · 2019 · Springer eBooks
  62. DDX24 inhibits clear cell renal cell carcinoma progression by directly regulating AKR1B10
    Zhijun Li, Xinglin Li, Min Yang, Xiaofeng Pei, Taotao Que, Jianzhong Xian, Hongjun Jin · 2025 · Cellular Signalling
  63. Metabolic danger signals: TCA cycle metabolites regulate immunity and disease
    Tristram A. J. Ryan, Ivan Zanoni · 2026 · Cell chemical biology
  64. From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes: A Personal History
    Berton Zbar · 2013 · Colloquium Series on The Genetic Basis of Human Disease
  65. Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis
    Ricardo Sánchez‐Rodríguez, Julia Esperanza Torres‐Mena, Luis del Pozo‐Yauner, Julio Isael Pérez‐Carreón · 2016 · Exposure and Health
  66. Targeting Mitochondrial Enzymes in Pancreatic Cancer
    Gowru Srivani, Begum Dariya, Afroz Alam, Ganji Purnachandra Nagaraju · 2019 · Springer eBooks
  67. Oxidative Stress and Cancer: Role of the Nrf2-Antioxidant Response Element Signaling Pathway
    Munindra Ruwali, Rahul Shukla · 2022 · Springer eBooks
  68. Pathological Oxidation of PTPN12 Underlies ABL1 Phosphorylation in HLRCC
    Yang Xu, Paul P. Taylor, Joshua Andrade, Beatrix M. Ueberheide, Brian M. Shuch, Peter M. Glazer, Ranjit S. Bindra, Michael F. Moran, William Marston Linehan, Benjamin G. Neel · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Faculty Opinions recommendation of Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.
    Stuart A. Lipton · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  70. Predictive value of m1A-related genes in kidney renal clear cell carcinoma
    Tengfei Zhang, Ning Yang, Lei Xu, Tao Jiang, Botao Dong · 2023 · Research Square
  71. Molecular Biology and Genetics
    Jeffrey A. Klomp, Karl J. Dykema, Bin Tean Teh, Kyle Furge · 2013 · Springer eBooks
  72. The physiological, pharmacological and toxicological roles of Nrf2 in the kidney
    Luke M. Shelton · 2015 · University of Liverpool
  73. 'NRF said
    Nicola Jane McCarthy · 2011 · Nature reviews. Cancer
  74. KEAPing NRF in check
    Amy L. Donner · 2011 · Nature Chemical Biology
  75. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
    Abstr Act · 2016
  76. Cutaneous Hamartoneoplastic Disorders
    Katherine L. Nathanson · 2013 · Elsevier eBooks
  77. Síndrome de leiomiomatosis hereditaria y cáncer de células renales: revisión de la literatura
    Carolina Arenas Valencia, Clara Eugenia Arteaga Díaz · 2017 · Revista Urología Colombiana / Colombian Urology Journal
  78. Molecular and Chemical Modulation of NRF2 for Disease Intervention
    Bryan G. Harder · 2017 · UA Campus Repository (The University of Arizona)
  79. Succinate Dehydrogenase A (SDHA) Gene Mutation in Renal Cell Carcinoma: A New Subset of Hereditary Renal Cancer
    Takao Kamai, Hideyuki Abe, Satoshi Murakami, Hajime Kuroda, Tsengelmaa Jamiyan, Kyoko Arai, Ken‐Ichiro Yoshida · 2019
  80. Cancer of the Kidney
    Daniel J. Canter, Robert G. Uzzo · 2011 · Springer eBooks
  81. WITHDRAWN: Hereditary leiomyomatosis renal cell carcinoma: A rare case report
    Dalin Feng, Xiaoli Diao, Mingshuai Wang, Xiaodong Zhang, Jianwen Wang · 2019 · Urology Case Reports · Retracted
  82. Clinical characteristics and treatments of hereditary leiomyomatosis renal cell carcinoma: two case reports and literature review
    Dalin Feng, Mingshuai Wang, Xiaodong Zhang, Jianwen Wang · 2020 · Aktuelle Urologie
  83. Allied Domecq España: la gestión práctica de la inteligencia emocional
    María Teresa Sáenz Blanco · 2002 · Capital humano: revista para la integración y desarrollo de los recursos humanos
  84. マトリックスモデルとは何か?--治療プログラムの可能性と限界 (特集 DARS(Drug Addiction Recovery support)の理論と実践)
    俊彦 松本 · 2010
  85. Construction and validation of a robust genomic classifier for high-risk sporadic type 2 papillary renal cell carcinoma: support more accurate utilization of mTOR inhibitors
    Xingyin Tian, W. Xu, Aihetaimujiang Anwaier, Yue Wang, Hua-Lei Gan, Wen-Jie Luo, Hong-Kai Wang, Fang-Ning Wan, Yu Zhu, Dalong Cao et al. · 2021 · European Urology
  86. Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis
    Ricardo Sánchez‐Rodríguez, Julia Esperanza Torres‐Mena, Luis del Pozo‐Yauner, Julio Isael Pérez‐Carreón · 2017 · Biomarkers in disease
  87. Metabolic mapping of high-fit and low-fit individuals for human physiological health
    Joëlle J. E. Janssen · 2022
  88. Supplementary Table from Cyst(e)inase–Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer
    Barış Kerimoğlu, Candice Lamb, Ryan D. McPherson, Ergül Ergen, Everett M Stone, Aikseng Ooi · 2023
  89. Data from Cyst(e)inase–Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer
    Barış Kerimoğlu, Candice Lamb, Ryan D. McPherson, Ergül Ergen, Everett M Stone, Aikseng Ooi · 2023
  90. Data from Cyst(e)inase–Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer
    Barış Kerimoğlu, Candice Lamb, Ryan D. McPherson, Ergül Ergen, Everett M Stone, Aikseng Ooi · 2023
  91. Additional file 3 of Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
    Wang, Yue, Xi Tian, Shuxuan Zhu, Wenhao Xu, Aihetaimujiang Anwaier, Jiaqi Su, Hualei Gan, Yuanyuan Qu, Jian‐Yuan Zhao, Hailiang Zhang et al. · 2023 · Figshare
  92. Additional file 4 of Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
    Wang, Yue, Xi Tian, Shuxuan Zhu, Wenhao Xu, Aihetaimujiang Anwaier, Jiaqi Su, Hualei Gan, Yuanyuan Qu, Jian‐Yuan Zhao, Hailiang Zhang et al. · 2023 · Figshare
  93. Additional file 1 of Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
    Wang, Yue, Xi Tian, Shuxuan Zhu, Wenhao Xu, Aihetaimujiang Anwaier, Jiaqi Su, Hualei Gan, Yuanyuan Qu, Jian‐Yuan Zhao, Hailiang Zhang et al. · 2023 · Figshare
  94. Additional file 2 of Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
    Wang, Yue, Xi Tian, Shuxuan Zhu, Wenhao Xu, Aihetaimujiang Anwaier, Jiaqi Su, Hualei Gan, Yuanyuan Qu, Jian‐Yuan Zhao, Hailiang Zhang et al. · 2023 · Figshare
  95. Pregnancy-desiring older woman with FH-deficient uterine leiomyoma: Case report and literature review
    Meng Zuo, Jing Fu, Guotao Liao · 2025 · Aging Research
  96. A novel fumarate hydratase frameshift mutation in lung adenocarcinoma: A case report
    Haruko Nakagawa, Satoru Aoyama, Junko Yokobori, Haruhiko Furusawa, Takahiro Mitsumura, Akira Takemoto, Ken Yamagiwa, Masaaki Kawanishi, Yasunari Miyazaki, Sadakatsu Ikeda · 2025 · Cancer Genetics
  97. NRF2 Dysregulation and Its Implications in Renal Cell Carcinoma
    Bumjun Jang, Mi‐Kyoung Kwak · 2025 · Drug Targets and Therapeutics
  98. THE PRECLINICAL AND CLINICAL PHARMACOLOGY OF BENZALDEHYDE DIMETHANE SULFONATE (BEN) FOR THE TREATMENT OF RENAL CELL CARCINOMA
    Robert A. Parise · 2014 · D-Scholarship@Pitt (University of Pittsburgh)
  99. Next-Generation Sequencing in Kidney, Bladder, and Prostate Pathology
    Stefano Sioletic, Alessia Cimadamore, Elisa Melucci, Giuseppe Simone · 2026 · Current clinical pathology
  100. Renal cell carcinoma: molecular understanding and therapeutic development
    Tao Hou, Xiangmei Hua, Wei Min NI, Peiqiang Yan, Hiroyuki Inuzuka, Wenyi Wei · 2026 · Cell Death and Differentiation